According to a new report LAMEA Contrast Injector Systems Market, published by KBV research, the LAMEA Contrast Injector Systems Market Size would witness market growth of 9.5% CAGR during the forecast period (2017 – 2023).

The Brazil market held the largest share in the LAMEA Contrast Injector Systems Application in Interventional Cardiology Market by Country in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 10.8 % during the forecast period. The Argentina market is expected to witness a CAGR of 12.2% during (2017 – 2023).

The Injector Head market held the largest share in the LAMEA Contrast Injector Systems Consumables Market by Type in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 7.4 % during the forecast period. The Tubing market is expected to witness a CAGR of 9.3% during (2017 – 2023).

The Hospitals market held the largest share in the LAMEA Contrast Injector Systems Market Size by End User in 2016, thereby, achieving a market value of $8.9 million by 2023. The Diagnostics Centers market is expected to witness a CAGR of 8.7% during (2017 – 2023).

The Consumables market held the largest share in the Argentina Contrast Injector Systems Market by Product in 2016, and would continue to be a dominant market till 2023. The Contrast Injector Systems Accessories market is expected to witness a CAGR of 13.2% during (2017 – 2023).

Full Report: https://kbvresearch.com/lamea-contrast-injector-systems-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the LAMEA Contrast Injector Systems Market Size have been discussed in the report with the elaborated company profiles of General Electric (GE), Medtron AG, VIVID Imaging, Nemoto Kyorindo Co., Ltd., Bayer AG, ulrich GmbH & Co. KG, Sino Medical-Device Technology Co., Ltd, Shenzhen Seacrown Electromechanical Co., Ltd, Bracco Imaging S.p.A, and Guerbet SA.

LAMEA Contrast Injector Systems Market Size Segmentation

By Product

• Injector Systems
  • CT Injector Systems
  • MRI Injector Systems
  • Angiography Injector Systems
• Consumables
  • Injector Head
  • Syringes
  • Tubing
  • Other Consumables
• Accessories

By Application

• Interventional Radiology
• Interventional Cardiology
• Radiology

By End User

• Diagnostics Centers
• Clinics and Others
• Hospitals

By Geography

• Brazil Contrast Injector Systems Market Size
• Argentina Contrast Injector Systems Market Size
• UAE Contrast Injector Systems Market Size
• Saudi Arabia Contrast Injector Systems Market Size
• South Africa Contrast Injector Systems Market Size
• Nigeria Contrast Injector Systems Market Size
• Other LAMEA Country Contrast Injector Systems Market Size

Companies Profiled

• General Electric (GE)
• Medtron AG
• VIVID IMAGING
• Nemoto Kyorindo Co., Ltd.
• Bayer AG
• ulrich GmbH & Co. KG
• Sino Medical-Device Technology Co., Ltd
• Shenzhen Seacrown Electromechanical Co., Ltd
• Bracco Imaging S.p.A
• Guerbet SA

Unique Offerings from KBV Research

• Exhaustive coverage of LAMEA Contrast Injector Systems Market
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

Global Contrast Injector Systems Market

North America Contrast Injector Systems Market

Europe Contrast Injector Systems Market

Asia Pacific Contrast Injector Systems Market

The post Latin America, Middle East and Africa Contrast Injector Systems Market Size to register a growth of 9.5% CAGR appeared first on KBV Research News.